Navigating the Challenge: A Look at Cancer Care in Colombia
In Colombia, cancer claims the lives of approximately 56,000 people each year, impacting families and communities. While the country boasts an advanced stage diagnosis rate of 73%, alarming data reveals a worrisome reality for those battling this complex disease.
A Complex Picture Emerges
The Second Great Survey of Cancer Patients in Colombia offers a nuanced understanding of the struggles faced by patients nationwide. Conducted by the coalition All.Can Colombia, the study brings forth a sobering reality: over half of patients experience significant problems or unnecessary delays, particularly during diagnosis and treatment.
Although 83% of Colombians diagnosed with cancer expressed trust in their medical team’s commitment, the remaining percentage struggles with long wait times and bureaucratic obstacles, highlighting a healthcare system grappling with the constraints of financial pressures and geographic disparities.
Despite the 69% of patients opting for chemotherapy, coupled with the established expertise of the Colombian Association of Hematology and Oncology (ACHO), experts warn of a system fraught with fragmentation, worsening under the financial strain on the country’s healthcare sector. Nearly one-third of patients experience the unsettling reality of switching healthcare providers mid-treatment, indicating a critical need for a more unified and patient-catered approach.
Early Detection, Remaining Obstacles
While some progress has been made, with 37% of patients attributing their diagnoses to early detection programs offered by their healthcare provider (EPS), 44% lack consistent access to specialists within their geographical proximity. There are deep divides, particularly for rural residents where access to specialized care remains a glaring barrier.
The emotional and psychological toll accompanying diagnoses further complicates the landscape.
While five out of ten participants reported receiving emotional and psychological support, only 12% reaches out to patient support groups. This suggests a gap in awareness regarding critical support networks. Furthermore, despite approximately 2 out of 10 patients identifying their cancer through pre-existing medical screenings originally designed for other conditions, early detection remains a critical undefeated enemy. The emphasis should be on bolstering nationwide activations for routine screenings aimed at catching cancers in their initial, treatable stages.
Yolima Méndez, president of the Colombian Leukemia and Lymphoma Foundation, emphasizes this fragmentation when she states, “Patients complain about fragmentation because this directly affects the opportunity and quality of care, in addition to continuity in treatment and quality of life.”
Professor Ricardo Brugés globally highlights a number of aspects, beyond the perceived lack of privacy that patients describe. Lower odds of survival are a sobering reality, particularly for patients situated in rural Colombia, evidence for delaying essentialits
th
Battling for Better Care
Despite the grim picture, voices like that of Jorge García, director of the Retorno Vital Patient Foundation bring a message of urgency, saying “Excelence in care and the guarantee that no patient is dependent on geographic location”
He heartily urges, “We cannot allow lives to continue to be lost while waiting for life-saving treatments. It is crucial to integrate all actors in the health system, including patient organizations, to generate solutions based on evidence and scientific knowledge that truly benefit users and their families.” His words reflect the widespread call for immediate action and for the precipice on which Colombian cancer treatment stands.
Hope Amidst the Struggle